OCT2013, an ischaemia-activated antiarrhythmic prodrug, devoid of the systemic side effects of lidocaine.
Hesketh LM, Sikkel MB, Mahoney-Sanchez L, Mazzacuva F, Chowdhury RA, Tzortzis KN, Firth J, Winter J, MacLeod KT, Ogrodzinski S, Wilder CDE, Patterson LH, Peters NS, Curtis MJ.
Hesketh LM, et al. Among authors: mahoney sanchez l.
Br J Pharmacol. 2022 May;179(9):2037-2053. doi: 10.1111/bph.15764. Epub 2022 Jan 13.
Br J Pharmacol. 2022.
PMID: 34855992
Free article.